Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Schizophrenia Research

• Publication date

  2017-06-16

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2017.06.011PMID 28624138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promoter variant rs2301228 on the neural cell adhesion molecule 1 gene confers risk of schizophrenia in Han Chinese.

  2014cited by this paper
• NCAM1 and neurocognition in schizophrenia.

  2007cited by this paper
• Polysialylated Neural Cell Adhesion Molecule Is Involved in Induction of Long-Term Potentiation and Memory Acquisition and Consolidation in a Fear-Conditioning Paradigm

  2006cited by this paper
• Regulators of Neurite Outgrowth: Role of Cell Adhesion Molecules

  2004cited by this paper
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

  2003cited by this paper
• Contribution of the Neural Cell Adhesion Molecule to Neuronal and Synaptic Plasticity

  2001cited by this paper
• NCAM‐180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle

  1998cited by this paper
• The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system.

  1998cited by this paper
• Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia.

  1995cited by this paper
• Brain specific synaptosomal membrane proteins demonstrated by crossed immunoelectrophoresis

  1974cited by this paper

• Nucleus Accumbens Proteome Disbalance in an Adolescent Mouse Model of Schizophrenia and Nicotine Misuse Comorbidity

  2025cites this paper
• A scoping review of protein biomarkers for schizophrenia: state of progress, underlying biology, and methodological considerations.

  2024cites this paper
• Neural Cell Adhesion Molecule-1 Gene Polymorphism Increases the Risk of Cognitive Dysfunction in Schizophrenia Spectrum Disorder

  2024cites this paper
• The pathophysiological role of circulating adhesion molecules in schizophrenia: A systematic review and meta-analysis.

  2023cites this paper
• Schizophrenia as autoimmune disease: Involvement of Anti-NCAM antibodies.

  2023cites this paper
• Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome

  2023cites this paper
• Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice

  2022cites this paper
• Dysregulation of Synaptic Plasticity Markers in Schizophrenia

  2022cites this paper
• Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia

  2021cites this paper
• Relationship Between Neural Cell Adhesion Molecule-1 and Cognitive Functioning in Schizophrenia Spectrum Disorder

  2021cites this paper
• Electrochemical sensing of blood proteins for mild traumatic brain injury (mTBI) diagnostics and prognostics: towards a point-of-care application

  2021cites this paper
• Suicide Related Phenotypes in a Bipolar Sample: Genetic Underpinnings

  2021cites this paper
• Neuromuscular Junction Aging: A Role for Biomarkers and Exercise.

  2020cites this paper
• Decreased serum NCAM is positively correlated with hippocampal volumes and negatively correlated with positive symptoms in first-episode schizophrenia patients.

  2020cites this paper
• Plasma Biomarkers as Potential Predictors of Functional Dependence in Daily Life Activities after Ischemic Stroke: A Single Center Study

  2019cites this paper
• Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment

  2019cites this paper
• Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia.

  2019cites this paper
• NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders

  2018cites this paper
• Circulating APP, NCAM and Aβ serve as biomarkers for Alzheimer's disease.

  2018cites this paper